FIELD: medicine.
SUBSTANCE: invention relates to medicine, pediatrics and can be used in patients with arterial hypertension and obesity/excessive weight for predicting risk of development of metabolic and vascular complications at early stages of diseases, including metabolic syndrome. By method of echocardiography on anterior wall of right ventricle determined are presence of epicardial fat and its thickness, whose value being from 0.2 to 0.6 cm testifies to excess of visceral adipopexis and predicts high risk of development of early cardiovascular complications in childhood and adolescence.
EFFECT: method provides diagnostic and prognostic criterion of visceral adipopexis in childhood and adolescence, creating conditions for formation and progress of cardiovascular and metabolic complications.
1 dwg
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC TECHNIQUE FOR INSULIN RESISTANCE | 2014 |
|
RU2553943C1 |
METHOD FOR VISCERAL OBESITY DETERMINATION BASED ON MAGNETIC RESONANCE TOMOGRAPHY OF HEART | 2018 |
|
RU2721542C2 |
METHOD FOR EARLY NON-INVASIVE DIAGNOSIS OF METABOLIC DISORDERS IN CHILDREN AND ADOLESCENTS | 2020 |
|
RU2734336C1 |
METHOD OF DIAGNOSING OBESITY | 2023 |
|
RU2812582C1 |
METHOD FOR DIAGNOSING OBESITY | 2022 |
|
RU2804577C1 |
METHOD FOR DETERMINING THE PROBABILITY OF VISCERAL OBESITY IN A PATIENT WITH OBSTRUCTIVE SLEEP APNEA-HYPOPNEA BY FOUR ANTHROPOMETRIC SIGNS | 2020 |
|
RU2742798C1 |
METHOD OF PREDICTING THE RISK OF ATRIAL FIBRILLATION IN MEN WITH CORONARY HEART DISEASE AND ARTERIAL HYPERTENSION | 2022 |
|
RU2802390C1 |
METHOD OF DIAGNOSTICS OF METABOLIC SYNDROME BY ULTRASONIC LIPOMETRY | 2017 |
|
RU2677526C1 |
ULTRASONIC METHOD OF DETERMINING THICKNESS OF ADIPOSE TISSUE IN ABDOMINAL AREA | 2012 |
|
RU2525664C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING DIASTOLIC DYSFUNCTION OF THE LEFT VENTRICLE IN OBESE PATIENTS | 2021 |
|
RU2774023C1 |
Authors
Dates
2011-08-27—Published
2009-06-01—Filed